JP2005508337A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508337A5 JP2005508337A5 JP2003530699A JP2003530699A JP2005508337A5 JP 2005508337 A5 JP2005508337 A5 JP 2005508337A5 JP 2003530699 A JP2003530699 A JP 2003530699A JP 2003530699 A JP2003530699 A JP 2003530699A JP 2005508337 A5 JP2005508337 A5 JP 2005508337A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- alkyl
- compound
- halogen
- physiologically functional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 229910052736 halogen Chemical group 0.000 claims 3
- 150000002367 halogens Chemical group 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 101700043017 NTRK1 Proteins 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001404 mediated Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Claims (6)
- 治療有効量の請求項1〜4のいずれか1項に記載の化合物又はその塩、溶媒和物若しくは生理学的に機能する誘導体及び1種以上の医薬上許容される担体、希釈剤及び賦形剤を含む医薬組成物。
- 不適切TrkA活性が介在する疾患の治療で使用されるための医薬の製造における請求項1〜5のいずれか1項に記載の化合物又はその塩、溶媒和物若しくは生理学的に機能する誘導体の使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32601201P | 2001-09-27 | 2001-09-27 | |
PCT/US2002/030150 WO2003027111A1 (en) | 2001-09-27 | 2002-09-24 | Chemical compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005508337A JP2005508337A (ja) | 2005-03-31 |
JP2005508337A5 true JP2005508337A5 (ja) | 2005-12-22 |
Family
ID=23270442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003530699A Pending JP2005508337A (ja) | 2001-09-27 | 2002-09-24 | 化合物 |
Country Status (7)
Country | Link |
---|---|
US (2) | US7015231B2 (ja) |
EP (1) | EP1430053B1 (ja) |
JP (1) | JP2005508337A (ja) |
AT (1) | ATE343575T1 (ja) |
DE (1) | DE60215682T2 (ja) |
ES (1) | ES2275021T3 (ja) |
WO (1) | WO2003027111A1 (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004508366A (ja) | 2000-09-01 | 2004-03-18 | グラクソ グループ リミテッド | オキシインドール誘導体 |
US7071217B2 (en) | 2000-09-01 | 2006-07-04 | Smithkline Beecham Corporation | Substituted oxindole derivatives as tyrosine kinase inhibitors |
DE60215682T2 (de) * | 2001-09-27 | 2007-09-06 | Smithkline Beecham Corp. | AZAOXOINDOL DERIVATE ALS Trk PROTEIN KINASE HEMMSTOFFE ZUR BEHANDLUNG VON KREBS UND CHRONISCHEM SCHMERZ |
ATE530545T1 (de) | 2005-02-04 | 2011-11-15 | Astrazeneca Ab | Als kinaseinhibitoren geeignete pyrazolylaminopyridinderivate |
DK1853602T3 (da) * | 2005-02-16 | 2010-09-20 | Astrazeneca Ab | Kemiske forbindelser |
ES2308731T3 (es) | 2005-02-16 | 2008-12-01 | Astrazeneca Ab | Compuestos quimicos. |
ES2391783T3 (es) | 2005-10-28 | 2012-11-29 | Astrazeneca Ab | Derivados de 4-(3-aminopirazol)pirimidina para su uso como agentes inhibidores de las tirosina cinasas en el tratamiento del cáncer |
US7514435B2 (en) * | 2005-11-18 | 2009-04-07 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
CA2649043C (en) | 2006-04-19 | 2013-09-17 | Astellas Pharma Inc. | Azolecarboxamide derivative |
PL2206707T3 (pl) | 2007-10-24 | 2015-01-30 | Astellas Pharma Inc | Związek azolokarboksamidowy lub jego sól |
EP2292089A1 (en) | 2008-01-11 | 2011-03-09 | Astellas Pharma Inc. | Model animal having both pain in testis or testis-related discomfort actions and frequent urination |
WO2010077680A2 (en) * | 2008-12-08 | 2010-07-08 | Vm Discovery Inc. | Compositions of protein receptor tyrosine kinase inhibitors |
BR112012025343A2 (pt) * | 2010-04-15 | 2016-06-28 | Merck Patent Gmbh | processo para a preparação de hidroquinonas |
US8999992B2 (en) | 2013-03-15 | 2015-04-07 | Vm Pharma Llc | Crystalline forms of tryosine kinase inhibitors and their salts |
CN103804273B (zh) * | 2014-01-27 | 2016-06-15 | 贵州大学 | 氧化吲哚与茚三酮双季碳拼接衍生物及其制备方法 |
US10231965B2 (en) | 2014-02-20 | 2019-03-19 | Ignyta, Inc. | Molecules for administration to ROS1 mutant cancer cells |
US10301271B2 (en) | 2014-09-17 | 2019-05-28 | Purdue Pharma L.P. | Crystalline forms of tyrosine kinase inhibitors and their salts |
WO2016089760A1 (en) | 2014-12-02 | 2016-06-09 | Ignyta, Inc. | Combinations for the treatment of neuroblastoma |
CA3008663A1 (en) | 2015-12-18 | 2017-06-22 | Ignyta, Inc. | Combinations of a selective tyrosine kinase inhibitor (tki) with a mek or erk inhibitor for the treatment of cancer |
BR112020000793A2 (pt) | 2017-07-19 | 2020-07-14 | Ignyta, Inc. | composições farmacêuticas e formas de dosagem |
WO2019077506A1 (en) | 2017-10-17 | 2019-04-25 | Ignyta, Inc. | PHARMACEUTICAL COMPOSITIONS AND SOLID GALENIC FORMS |
EA202192575A1 (ru) | 2019-03-21 | 2022-01-14 | Онксео | Соединения dbait в сочетании с ингибиторами киназ для лечения рака |
EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9423997D0 (en) * | 1994-11-28 | 1995-01-11 | Erba Carlo Spa | Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
GB9716557D0 (en) * | 1997-08-06 | 1997-10-08 | Glaxo Group Ltd | Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity |
GB9721437D0 (en) * | 1997-10-10 | 1997-12-10 | Glaxo Group Ltd | Heteroaromatic compounds and their use in medicine |
WO2000008202A2 (en) * | 1998-08-04 | 2000-02-17 | Sugen, Inc. | 3-methylidenyl-2-indolinone modulators of protein kinase |
DE60215682T2 (de) * | 2001-09-27 | 2007-09-06 | Smithkline Beecham Corp. | AZAOXOINDOL DERIVATE ALS Trk PROTEIN KINASE HEMMSTOFFE ZUR BEHANDLUNG VON KREBS UND CHRONISCHEM SCHMERZ |
-
2002
- 2002-09-24 DE DE60215682T patent/DE60215682T2/de not_active Expired - Fee Related
- 2002-09-24 AT AT02799606T patent/ATE343575T1/de not_active IP Right Cessation
- 2002-09-24 ES ES02799606T patent/ES2275021T3/es not_active Expired - Lifetime
- 2002-09-24 US US10/490,831 patent/US7015231B2/en not_active Expired - Fee Related
- 2002-09-24 JP JP2003530699A patent/JP2005508337A/ja active Pending
- 2002-09-24 WO PCT/US2002/030150 patent/WO2003027111A1/en active IP Right Grant
- 2002-09-24 EP EP02799606A patent/EP1430053B1/en not_active Expired - Lifetime
-
2006
- 2006-01-20 US US11/336,010 patent/US20060128745A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005508337A5 (ja) | ||
JP2006523216A5 (ja) | ||
JP2021100937A5 (ja) | ||
JP2006526590A5 (ja) | ||
JP2004517099A5 (ja) | ||
JP2004517049A5 (ja) | ||
JP2006182786A5 (ja) | ||
JP2020507589A5 (ja) | ||
JP2004516314A5 (ja) | ||
JP2006509749A5 (ja) | ||
JP2004509061A5 (ja) | ||
WO2006098918A3 (en) | Substituted gamma lactams as therapeutic agents | |
JP2008526999A5 (ja) | ||
RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
JP2008513510A5 (ja) | ||
MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
JP2003503449A5 (ja) | ||
JP2008500378A5 (ja) | ||
JP2004517098A5 (ja) | ||
JP2009506043A5 (ja) | ||
JP2002525323A5 (ja) | ||
JP2019533660A5 (ja) | ||
JP2005513014A5 (ja) | ||
IL150817A0 (en) | Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases | |
JP2005538974A5 (ja) |